1. Targeting MOR-mGluR5 heteromers reduces bone cancer pain by activating MOR and inhibiting mGluR5. (1st December 2019) Authors: Shueb, Sarah S.; Erb, Samuel J.; Lunzer, Mary M.; Speltz, Rebecca; Harding-Rose, Catherine; Akgün, Eyup; Simone, Donald A.; Portoghese, Philip S. Journal: Neuropharmacology Issue: Volume 160(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗